Cargando…
A journey with no roadmap—The need for validated criteria of the MS prodrome
BACKGROUND: A growing body of compelling evidence has emerged to validate a set of signs and symptoms that indicates the onset of disease before more typical signs and symptoms present to fulfill a diagnosis of MS. On 24 June 2021, a group of international researchers, patient advocates, and Society...
Autor principal: | Roman, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152209/ https://www.ncbi.nlm.nih.gov/pubmed/36346144 http://dx.doi.org/10.1177/13524585221135883 |
Ejemplares similares
-
Sharing data from MS clinical trials: Opportunities, challenges, and future directions
por: Coetzee, Timothy
Publicado: (2015) -
Computed tomography for ventral hernia: Need for a standardised reporting format
por: Gandhi, Jignesh A., et al.
Publicado: (2023) -
Transplant Medicine in China: Need for Transparency and International Scrutiny Remains
por: Trey, T., et al.
Publicado: (2016) -
The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022) -
A roadmap for human trials of xenotransplantation
por: Porrett, Paige M., et al.
Publicado: (2022)